Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3002067	du-iglcl	— (—)	623	1855	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

153

138.20

305.06

3.1

1.3

—

Transplanted organ and tissue status

100

18.26

124.45

4.8

3.8

—

Amyloidosis

32.98

67.93

4.1

4.6

—

Oxycodone

134

238

4.83

57.02

3.8

2.8

—

Donors of organs and tissues

123.00

52.75

2.9

1.2

—

Disorders of calcium metabolism

9.69

36.85

5.2

3.5

—

Amyloidosis, other/unspecified

49.37

35.08

4.2

4.6

—

Disorders of mineral metabolism

8.27

34.21

5.0

3.9

—

Hypercalcemia

9.90

30.38

4.4

3.4

—

Malignant immunoproliferative diseases

65.05

26.39

1.9

1.6

—

Solid cancers, including Hilmo

160

3.17

18.86

3.1

1.6

—

Viral pneumonia

5.09

18.79

3.7

2.6

—

Any reimbursement code in KELA

5.47

18.70

3.3

1.7

—

Solid cancers

160

3.15

18.53

3.2

1.6

—

Diabetic nephropathy, excluding more controls

4.43

17.61

2.3

2.5

—

Other medical care

285

2.74

17.53

3.5

2.8

—

Hyperkalaemia

5.90

13.52

3.1

3.4

—

Osteonecrosis due to drugs

23.20

12.97

3.0

2.3

—

Diabetic nephropathy

136

3.36

12.82

2.3

2.4

—

Presence of other functional implants

290

2.32

12.59

2.8

—

Other disorders of fluid, electrolyte and acid-base balance

210

2.79

12.50

2.6

3.1

—

Spondylopathies in diseases classified elsewhere

16.42

12.23

4.6

1.8

—

Persons encountering health services in other circumstances

254

2.61

12.10

3.1

3.0

—

Malignant neoplasm of skin, including Hilmo

145

2.87

12.07

3.1

1.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3.80

12.05

2.9

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

127

3.00

11.81

2.7

1.5

—

Streptococcal septicaemia, including avohilmo

4.47

11.65

3.5

2.7

—

Non-Hodgkin lymphoma, all, including Hilmo

4.74

11.64

2.3

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

135

2.90

11.58

3.2

1.5

—

Atrial fibrillation and flutter with reimbursement

3.43

11.18

2.1

3.1

—

Explicit bacterial Sepsis, including avohilmo

4.07

11.11

3.8

3.3

—

Cardiomyopathy

106

3.50

11.09

2.3

2.9

—

Malaise and fatigue

265

2.35

10.90

2.8

2.9

—

Streptococcal septicaemia

4.31

10.75

3.6

2.7

—

Viral pneumonia (known virus, not influenza)

14.36

10.50

3.9

3.3

—

Malignant neoplasm of skin

140

2.76

10.46

2.5

1.6

—

Explicit bacterial Sepsis

3.93

10.28

3.9

3.3

—

Valvular heart disease excluding rheumatic fever

228

2.35

10.17

4.0

3.1

—

Non-rheumatic valve diseases

228

2.35

10.15

4.0

3.1

—

Chronic nephritic syndrome

11.37

10.06

3.1

5.2

—

Basal cell carcinoma, including Hilmo

128

2.75

9.55

3.1

1.5

—

Heart failure and bmi 25plus

202

2.35

9.46

2.1

3.4

—

Organ-limited amyloidosis

+∞

9.45

2.8

0.0

—

Hypothyroidism, levothyroxine purchases

11.84

9.34

2.6

1.9

—

Hypothyroidism and >3 levothyroxin purchases

11.84

9.34

2.6

1.9

—

Hypothyroidism (congenital or acquired)

11.82

9.34

2.6

1.9

—

Depression medications

11.18

9.27

3.6

1.9

—

Hypertensive Renal Disease

9.03

8.53

2.5

3.7

—

Rare circulating lymphoid malignancy, including Hilmo

20.18

8.47

4.3

1.2

—

Other CVD (FINNGEN)

3.99

8.04

4.4

3.4

—

Secondary hypertension

5.99

7.73

4.4

3.3

—

Hyperlipidaemia, other/unspecified

278

2.14

7.62

2.0

3.0

—

Cardiovascular diseases (excluding rheumatic etc)

111

2.53

7.38

3.1

3.2

—

Asthma, unspecified (mode), excluding more controls

170

2.32

7.34

2.5

3.1

—

Codeine

278

1.89

7.17

2.8

—

Basal cell carcinoma

127

2.47

6.98

3.0

1.5

—

Other functional intestinal disorders

278

2.06

6.69

2.9

3.2

—

Hernia of abdominal wall, postoperative

3.47

6.62

1.9

3.1

—

Viral pneumonia (unknown virus, not influenza)

3.82

6.53

3.5

3.2

—

Medical observation and evaluation for suspected diseases and conditions

220

1.93

6.50

2.3

3.2

—

Failure and rejection of transplanted organs and tissues

18.28

6.28

5.9

4.4

—

Asthma, unspecified (mode)

199

2.10

6.24

2.6

2.9

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.49

6.02

1.8

4.1

—

Acute sinusitis

273

2.00

5.93

4.3

2.6

—

Pain in thoracic spine

2.90

5.87

3.0

3.6

—

Other/unspecified cytomegaloviral diseases

11.24

5.80

5.3

3.7

—

Cytomegaloviral disease

11.22

5.80

5.3

2.1

—

Cytomegaloviral disease, including avohilmo

11.21

5.80

5.3

2.1

—

Other arrhythmias

287

1.87

5.70

2.8

3.2

—

Cardiovascular diseases

2.38

5.69

2.9

3.1

—

Nausea and vomiting

170

2.30

5.68

2.4

3.1

—

Paroxysmal tachycardia

2.84

5.67

1.6

3.2

—

Hypothyroidism, drug reimbursement

9.60

5.47

4.8

1.9

—

Diabetic retinopathy, excluding more controls

2.38

5.42

2.6

2.4

—

Fitting and adjustment of other devices

243

2.00

5.41

2.0

2.8

—

Primary hyperparathyroidism

2.96

5.40

1.7

2.8

—

Other dialysis

6.25

5.39

3.1

3.8

—

Cytomegalovirus infection, IBD co-morbidity

9.18

5.29

5.3

3.2

—

Secondary systemic amyloidosis

+∞

5.24

4.0

0.0

—

Spondylopathies

350

1.67

5.17

2.8

3.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.58

5.13

2.8

1.6

—

Malignant neoplasm of breast, including Hilmo

2.58

5.13

2.8

1.6

—

Hypo-osmolality and hyponatraemia

114

2.53

5.11

2.0

3.4

—

Hypoparathyroidism

6.36

5.08

4.9

2.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

107

2.30

5.07

2.8

3.3

—

Acquired haemolytic anaemia

8.41

5.07

2.2

3.0

—

Malignant neoplasm of endocrine gland

6.89

4.95

5.6

1.7

—

Generalized skin eruption due to drugs and medicaments

6.04

4.91

5.5

3.1

—

Osteoporosis with pathological fracture (FG)

3.35

4.88

1.5

2.3

—

Malignant neoplasm of breast, HER2-negative

2.55

4.87

2.9

1.6

—

Malignant neoplasm of breast

2.55

4.87

2.9

1.6

—

Antihypertensive medication - note that there are other indications

115

2.09

4.60

2.5

3.9

—

Malignant neoplasm of endocrine gland, including Hilmo

5.47

4.59

5.3

1.5

—

Pneumocystosis, including avohilmo

8.27

4.57

4.3

3.2

—

Pneumocystosis

8.27

4.57

4.3

3.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.60

4.55

3.3

3.9

—

Acute generalized exanthematous pustulosis

4.84

4.50

5.4

3.6

—

Haemolytic anaemias

6.71

4.47

2.2

3.7

—

Secondary uncertain malignant neoplasm

3.21

4.33

1.6

—

Asthma (mode)

204

1.75

4.14

2.6

2.9

—

Myeloid leukaemia

6.47

3.99

3.2

2.9

—

Malignant neoplasm of thyroid gland

6.44

3.98

6.6

1.4

—

Other/unspecified dorsalgia

243

1.87

3.93

3.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2.89

3.89

2.2

1.7

—

Myelodysplastic syndrome, including Hilmo

7.31

3.86

1.5

1.1

—

Protozoal diseases

5.30

3.83

4.0

2.6

—

Protozoal diseases, including avohilmo

5.30

3.83

4.0

2.6

—

Hypocalcemia

6.05

3.82

7.8

2.9

—

Asthma, excluding more controls

170

1.78

3.81

2.6

3.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

4.30

3.81

1.8

—

Disorders of continuity of bone

3.07

3.80

4.1

2.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

12.06

3.76

1.2

—

Asthma (only as main-diagnosis), excluding more controls

170

1.79

3.68

2.4

3.1

—

Malignant neoplasm of thyroid gland, including Hilmo

5.64

3.65

6.6

1.5

—

Asthma

201

1.69

3.62

2.5

2.9

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2.72

3.50

4.1

1.5

—

Immunodeficiency with predominantly antibody defects

6.19

3.50

1.8

2.9

—

Presence of other devices

162

2.01

3.48

1.6

2.7

—

Retained placenta and membranes, without haemorrhage

2.98

3.41

2.4

2.6

—

Squamous cell neoplasms and carcinomas of the skin

2.98

3.40

2.3

1.5

—

Dermatitis due to substances taken internally

3.76

3.38

5.5

3.8

—

Myocarditis

5.01

3.37

3.1

4.3

—

Implicit fungal Sepsis

4.19

3.19

4.1

3.0

—

Drug-induced osteoporosis with pathological fracture

6.42

3.19

1.3

2.8

—

Continuous positive airway pressure

101

2.15

3.19

1.9

3.6

—

Symptoms and signs concerning food and fluid intake

2.54

3.10

1.8

2.7

—

Myalgia

145

2.00

3.09

2.7

3.4

—

Immunodeficiencies

4.02

3.08

2.3

2.9

—

Other autoimmune haemolytic anaemias

7.58

3.06

1.3

2.1

—

Malignant neoplasm of other connective and soft tissue

7.54

3.06

6.0

1.1

—

Non-Hodgkin lymphoma, all

5.02

3.05

1.6

—

Chronic tubulo-interstitial nephritis

5.02

3.05

1.3

3.6

—

Volume depletion

2.59

3.04

1.8

3.8

—

Malignant neoplasm of breast, HER-positive

2.28

3.03

2.4

1.5

—

Syncope and collapse

254

1.68

3.03

2.6

2.8

—

Malignant neoplasm of breast, ER-positive, including Hilmo

2.27

3.02

2.4

1.5

—

Menorrhagia

1.96

2.95

2.0

2.9

—

Complications predominantly related to the puerperium

2.27

2.93

2.7

2.9

—

Papillary adenocarcinoma of thyroid gland

6.68

2.87

8.8

1.6

—

Other symptoms and signs involving the digestive system and abdomen

109

2.11

2.83

1.5

3.0

—

Sicca syndrome [Sjögren]

2.77

2.81

1.5

2.7

—

Carcinoma in situ of skin of trunk

3.59

2.78

4.0

2.6

—

Neurological diseases, wide definition

2.68

2.73

3.4

3.8

—

Pain in joint

233

1.58

2.73

2.4

3.3

—

Giant cell arteritis with polymyalgia rheumatica

3.47

2.69

1.2

2.6

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

4.22

2.67

4.9

1.6

—

Pain, not elsewhere classified

161

1.86

2.65

1.9

2.7

—

Fungal Sepsis

3.35

2.60

4.1

2.8

—

Asthma (only as main-diagnosis)

201

1.59

2.58

2.5

2.9

—

Other disorders of bone density and structure

7.17

2.55

1.2

3.9

—

Malignant melanoma, including Hilmo

2.36

2.55

1.8

1.7

—

Heart failure and hypertrophic cardiomyopathy

5.49

2.55

2.7

4.2

—

Cerebrovascular diseases (FINNGEN)

1.93

2.49

3.4

—

Giant cell arteritis

2.99

2.49

1.2

2.7

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2.98

2.48

1.6

—

Other specified/unspecified spondylopathies

3.83

2.46

1.4

3.6

—

Other diseases of spinal cord

3.83

2.46

3.5

3.4

—

Malignant melanoma

2.38

2.46

1.7

1.6

—

Temporal arteritis

3.14

2.43

1.2

2.5

—

Enlarged lymph nodes

2.09

2.42

2.7

2.8

—

Cardiomyopathies, Primary/intrinsic

2.29

2.41

1.8

3.1

—

Orthopaedic devices associated with adverse incidents

5.03

2.40

1.8

3.0

—

Malignant neoplasm of mesothelium and soft tissue

5.01

2.40

6.0

1.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

5.01

2.40

6.0

1.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

3.35

2.39

5.6

2.9

—

malignant neoplasm of female genital organs, including Hilmo

2.53

2.38

2.9

1.6

—

Postzoster neuralgia

6.29

2.37

1.2

1.6

—

Diverticular disease of intestine

378

1.42

2.37

2.5

3.2

—

Small fibre neuropathy

3.65

2.36

2.3

3.7

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

4.12

2.36

2.0

1.8

—

Malignant neoplasm of urinary organs, including Hilmo

2.61

2.35

1.6

—

Conduction disorders

157

1.74

2.34

2.0

2.9

—

Cardiomyopathy (excluding other)

2.26

2.34

1.8

3.1

—

malignant neoplasm of male genital organs, including Hilmo

1.95

2.31

3.2

1.6

—

Other disorders of white blood cells

2.95

2.28

1.8

3.6

—

Factors influencing health status and contact with health services

1.91

2.26

3.6

2.8

—

Amputation of ankle bones

5.58

2.21

2.2

3.6

—

ILD, hospital admissions 3, with pneumonia sepsis

2.24

2.17

1.8

2.4

—

Varicella [chickenpox]

3.69

2.15

7.7

3.9

—

Acute pharyngitis

2.39

2.15

1.8

3.1

—

Covid-19 suspected case

108

1.95

2.14

5.4

2.9

—

Varicella [chickenpox], including avohilmo

3.50

2.05

7.7

3.8

—

ILD, hospital admission 2, with pulmonary infections

2.18

2.04

1.8

2.4

—

Cardiomyopathy, other and unspecified

2.40

2.02

1.8

3.2

—

ILD medications: azathioprine

2.50

2.01

2.2

2.0

—

Bacterial, viral and other infectious agents

2.64

2.00

5.2

3.6

—

Malignant neoplasm of prostate, including Hilmo

1.86

1.98

3.3

1.6

—

Disorders of thyroid, IBD co-morbidities

2.51

1.87

2.7

3.8

—

Malignant neoplasm of kidney, except renal pelvis

2.65

1.86

1.7

1.6

—

malignant neoplasm of female genital organs

2.39

1.84

2.4

1.6

—

Other and unspecified drugs and medicaments

2.21

1.84

6.2

2.9

—

Carcinoma in situ of skin, other sites/unspecified

4.19

1.82

3.6

2.1

—

Drug-induced cataract

4.18

1.82

1.4

3.1

—

Hodgkin lymphoma, hilmo

4.18

1.82

2.6

4.8

—

Other and unspecified disorders of white blood cells

3.05

1.80

1.6

3.7

—

Convalescence

2.76

1.79

3.3

2.9

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1.85

1.75

1.8

1.6

—

malignant neoplasm of male genital organs

1.80

1.74

3.3

1.6

—

Malignant neoplasm of urinary organs

2.50

1.74

1.7

1.6

—

Disorders of oesophagus in diseases classified elsewhere

3.86

1.71

6.4

4.2

—

Testicular hypofunction

3.85

1.71

1.8

4.5

—

Bacterial pneumoniae

232

1.51

1.71

3.5

2.4

—

Care involving use of rehabilitation procedures

350

1.41

1.68

3.0

—

Bacterial, viral and other infectious agents, including avohilmo

2.50

1.66

5.2

3.6

—

Follow-up care involving plastic surgery

3.17

1.66

2.8

3.7

—

Infectious mononucleosis, including avohilmo

3.16

1.66

2.2

4.2

—

Infectious mononucleosis

3.16

1.66

2.2

4.2

—

Gingival hyperplasia

2.81

1.65

1.6

3.9

—

Other endocrine disorders

3.69

1.65

2.2

3.2

—

Postmenopausal osteoporosis with pathological fracture

2.44

1.64

1.6

2.5

—

Diabetic retinopathy

189

1.48

1.64

2.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.87

1.63

1.8

1.7

—

Clear cell adenocarcinoma of kidney

3.58

1.61

2.0

1.6

—

Other puerperal infections

3.57

1.61

1.8

3.6

—

Excessive, frequent and irregular menstruation

1.65

1.61

2.4

2.9

—

Fibromyalgia

2.33

1.58

1.4

3.4

—

Dysplasia of cervi uteri

1.86

1.58

2.6

3.0

—

Implicit fungal Sepsis, including avohilmo

2.20

1.57

3.8

2.7

—

Unspecified/other endometriosis

2.64

1.54

2.4

3.4

—

Other abnormal findings of blood chemistry

2.43

1.53

2.8

3.0

—

Other obstructed labour

2.43

1.53

4.5

2.8

—

Non-small cell lung cancer, including Hilmo

2.03

1.52

2.2

1.7

—

Chorioretinal inflammation

3.34

1.52

2.0

3.5

—

Testicular dysfunction

3.34

1.52

1.8

4.1

—

Eustachian salpingitis and obstruction

2.60

1.51

2.9

3.2

—

therapeutic use

2.87

1.50

1.8

3.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2.00

1.48

6.2

2.8

—

Malignant neoplasm of prostate

1.71

1.45

3.4

1.6

—

Later onset COPD, excluding more controls

123

1.61

1.45

2.6

2.3

—

Diseases of tongue

2.50

1.45

3.0

2.5

—

Discitis, unspecified

3.14

1.44

2.0

3.7

—

Other and unspecified injuries of shoulder and upper arm

3.13

1.44

1.4

3.6

—

Diffuse large B-cell lymphoma, including Hilmo

3.13

1.44

1.4

1.5

—

Diffuse large B-cell lymphoma, helper endpoint

3.13

1.44

1.4

1.5

—

Diffuse large B-cell lymphoma

3.13

1.44

1.4

1.5

—

Non-small cell lung cancer

2.20

1.42

2.0

1.5

—

Other disorders of adrenal gland

2.61

1.36

1.5

3.5

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

1.34

0.0

2.7

—

Trigeminal neuralgia

0.00

1.34

0.0

3.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

1.33

0.0

2.8

—

Familial hypercholesterolemia

105

1.72

1.32

1.4

3.4

—

Olecranon bursitis

2.04

1.32

1.1

3.2

—

Puerperal sepsis

1.97

1.32

3.2

2.4

—

Dislocation, sprain and strain of joints and ligaments of thorax

2.78

1.28

4.8

4.3

—

Urinary track infection

135

1.45

1.28

2.7

3.0

—

Hypertrophic cardiomyopathy

2.29

1.27

4.0

3.1

—

Other specified/unspecified systemic involvement of connective tissue

2.29

1.27

1.3

3.4

—

Parkinson's disease, excluding more controls

107

0.43

1.25

3.0

3.1

—

Single delivery by forceps and vacuum extractor

2.56

1.25

2.2

3.4

—

Disorders resulting from impaired renal tubular function

2.41

1.24

1.3

3.9

—

Non-small cell lung cancer, adenocarcinoma

2.40

1.24

2.7

1.8

—

Unknown and unspecified causes of morbidity

2.23

1.24

1.5

2.4

—

Dysphagia

195

1.49

1.23

2.0

3.1

—

Spinal stenosis

323

1.32

1.23

3.1

3.2

—

Other and unspecified mononeuropathies of upper limb

2.64

1.21

2.4

3.6

—

Pneumococcal septicemia

2.64

1.21

4.0

4.2

—

Endocarditis

2.64

1.21

1.4

3.1

—

Chondrocostal junction syndrome [Tietze]

2.64

1.21

1.8

3.4

—

Other and unspecified injuries of wrist and hand

2.64

1.21

3.0

2.8

—

Multiple delivery

2.63

1.21

4.6

3.2

—

Other disorders of the genitourinary system

1.72

1.21

3.1

2.6

—

Spondylosis

339

1.31

1.17

2.1

3.1

—

Acute posthaemorrhagic anaemia

2.50

1.15

4.0

3.1

—

Pruritus

1.81

1.15

2.4

3.0

—

Ovarian cyst

1.54

1.14

2.2

2.9

—

Malignant neoplasm of breast, ER-negative, including Hilmo

1.84

1.11

3.3

1.5

—

Assault

1.96

1.11

1.5

3.6

—

Otitis media, unspecified

1.99

1.11

1.8

3.3

—

Cystitis

359

1.26

1.10

2.8

2.9

—

Contraceptive management

163

0.60

1.09

3.4

3.2

—

Other complications of surgical and medical care, not elsewhere classified

1.82

1.09

3.8

3.1

—

Complications of labour and delivery

171

1.36

1.06

3.0

2.7

—

Tobacco use

2.12

1.05

1.0

3.8

—

Pneumonia derived septicemia

2.28

1.03

4.0

3.8

—

Scabies

2.28

1.03

1.4

3.8

—

Leiomyoma of uterus

198

1.33

1.03

3.3

2.6

—

Type 1 diabetes, definitions combined

2.27

1.03

1.2

3.3

—

Abnormalities of forces of labour

2.06

1.02

4.6

3.3

—

Diabetic neuropathy

1.63

1.01

2.0

2.4

—

Sciatica+with lumbago

325

1.31

1.01

3.0

3.2

—

Soft tissue disorders related to use, overuse and pressure

205

1.42

1.00

2.2

3.3

—

Malignant neoplasm of breast, HER-negative

1.82

1.00

3.4

1.5

—

Parkinson's disease, strict definition, excluding more controls

103

0.45

1.00

3.0

2.9

—

Infective bursitis

2.18

0.98

3.4

4.3

—

Benign neoplasm of thyroid gland

2.18

0.98

9.6

2.7

—

Carpal tunnel syndrome

419

1.26

0.98

2.5

3.2

—

Bacterial pneumonia, not elsewhere classified

225

1.37

0.98

2.8

2.4

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.97

0.0

3.1

—

Type 1 diabetes, strict (exclude DM2)

2.17

0.97

1.2

3.4

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.97

0.0

4.1

—

Hypertrophic disorders of skin

0.00

0.97

0.0

3.0

—

Poor fetal growth

0.00

0.97

0.0

3.3

—

Oesophageal obstruction

0.00

0.97

0.0

3.4

—

Pustulosis palmaris et plantaris

0.00

0.96

0.0

3.4

—

Recurrent dislocation and subluxation of joint

0.00

0.96

0.0

3.1

—

Malignant neoplasm of bronchus and lung

1.67

0.96

2.1

1.7

—

Malignant neoplasm of bronchus and lung, including Hilmo

1.61

0.95

2.0

1.7

—

Hypokalaemia

1.69

0.95

3.0

3.8

—

Examination and encounter for administrative purposes

1.78

0.94

1.5

3.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.78

0.94

6.2

3.3

—

Assault by bodily force

2.22

0.93

1.5

3.7

—

Other menopausal disorders

0.56

0.92

3.7

2.9

—

Long labour

1.72

0.91

3.5

3.2

—

Secondary right heart disease

2.15

0.91

3.3

—

Pediculosis, acariasis and other infestations

2.15

0.91

1.3

4.1

—

Hypopituitarism

2.14

0.91

4.8

3.7

—

AV-block

107

1.52

0.91

1.9

2.7

—

Other intracranial haemorrhages

2.07

0.89

7.0

2.4

—

Benign leiomyoma with endometriosis

102

0.49

0.89

2.2

2.5

—

Other or unspecified ileus, impaction or obstruction

127

1.50

0.88

1.9

3.1

—

Other diseases of intestine

111

1.53

0.87

2.6

3.3

—

Undetermined asthma, excluding more controls

1.79

0.87

4.3

2.3

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

178

0.66

0.86

4.2

2.9

—

Paracetamol or NSAID medication

1.79

0.85

2.4

2.8

—

Gestational diabetes (for exclusion)

0.52

0.85

1.5

3.8

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.94

0.84

1.7

3.4

—

Crohn's disease of small intestine

1.94

0.84

1.5

3.3

—

Unspecified urinary incontinence

1.76

0.83

1.3

2.6

—

Colorectal cancer

100

1.54

0.83

2.4

1.6

—

Malignant neoplasm of colon

1.69

0.82

3.0

1.5

—

Other female pelvic inflammatory diseases

1.57

0.81

3.4

2.6

—

Malignant neoplasm of digestive organs

124

1.42

0.81

2.4

1.5

—

Polycystic ovarian syndrome, consortium definition

222

1.27

0.80

3.5

2.8

—

Malignant neoplasm of digestive organs, including Hilmo

132

1.39

0.79

2.4

1.6

—

Atopic conjunctivitis

0.00

0.79

0.0

2.9

—

Secondary parkinsonism, excluding more controls

0.00

0.79

0.0

3.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

1.82

0.79

3.5

3.2

—

Malignant neoplasm of corpus uteri, including Hilmo

1.82

0.79

3.0

1.7

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.79

0.0

2.8

—

Deep bite

1.67

0.78

1.6

3.1

—

Other specified/unspecified dorsopathies

0.00

0.78

0.0

3.1

—

Status epilepticus

0.00

0.78

0.0

4.8

—

Hypertrophic scar

0.00

0.78

0.0

3.2

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.77

0.0

3.1

—

Other and unspecified abdominal hernia

1.77

0.76

1.3

3.5

—

Other osteochondropathies

1.77

0.76

3.8

3.1

—

Use of biperiden

0.00

0.76

0.0

3.5

—

Fissure and fistula of anal and rectal regions

149

1.41

0.75

2.3

3.2

—

Sixth [abducent] nerve palsy

2.09

0.74

3.4

3.8

—

Malignant melanoma of skin, including Hilmo

1.64

0.73

1.3

1.6

—

Presence of cardiac and vascular implants and grafts

244

1.27

0.73

1.8

2.9

—

Cramp and spasm

2.00

0.72

3.2

3.4

—

Twin gestation

2.00

0.72

4.6

2.6

—

Other abnormal uterine and vaginal bleeding

1.45

0.72

3.6

2.9

—

Conductive hearing loss, unspecified

1.67

0.72

5.2

2.9

—

Heartburn

1.58

0.71

1.6

2.8

—

COPD (mode)

157

1.34

0.71

2.1

2.6

—

Vocal cord dysfunction

1.58

0.71

1.9

4.2

—

Arterial embolism and thrombosis of lower extremity artery

1.93

0.70

2.4

2.8

—

Pilonidal cyst

1.92

0.70

2.2

4.5

—

Multiple gestation

1.92

0.70

4.6

2.8

—

Impacted teeth

1.72

0.70

3.3

3.6

—

LSIL lesion of the cervix uteri

1.71

0.70

3.6

2.7

—

Colorectal cancer, including Hilmo

102

1.46

0.69

2.4

1.6

—

Other acquired deformities of musculoskeletal system and connective tissue

1.85

0.68

2.2

3.5

—

Other and unspecified coagulation defects

1.85

0.68

1.2

3.6

—

Melanoma in situ

1.67

0.68

2.3

3.1

—

Other and unspecified rosacea

1.60

0.68

1.6

3.0

—

Other metabolic disorders

1.60

0.68

6.2

3.2

—

Thoracic aortic aneurysm

127

1.42

0.67

4.1

3.0

—

All dysplastic lesions of the cervix uteri

1.55

0.67

2.8

3.0

—

Allergic urticaria

1.63

0.66

5.4

3.1

—

Pneumonia due to Streptococcus pneumoniae

1.79

0.66

5.6

2.9

—

Other diseases of pericardium

1.79

0.66

1.4

3.7

—

Paralytic ileus and intestinal obstruction

188

1.33

0.65

1.9

3.0

—

Haemorrhage in early pregnancy

116

1.42

0.65

2.3

3.4

—

Asthma and allergy, excluding more controls

1.76

0.65

3.2

2.5

—

Migraine without aura

1.61

0.65

4.3

3.8

—

Undetermined asthma

1.61

0.64

4.3

2.4

—

Postmenopausal atrophic vaginitis

1.36

0.64

2.1

2.9

—

Panniculitis affecting regions of neck and back

1.73

0.64

1.8

4.0

—

Chronic iridocyclitis

1.73

0.64

1.0

3.0

—

Abnormal findings on diagnostic imaging of central nervous system

1.73

0.64

2.2

3.9

—

Malignant neoplasm of corpus uteri

1.73

0.64

1.6

1.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

190

1.26

0.62

3.1

3.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.55

0.62

1.9

2.5

—

Otalgia

1.63

0.62

5.3

2.9

—

Disorders of synovium and tendon

328

1.22

0.61

2.4

3.3

—

Mixed hyperlipidaemia

1.67

0.61

1.0

4.1

—

Benign neoplasm: Skin of trunk

1.67

0.61

2.2

3.8

—

Other and unspecified follicular disorders

1.67

0.61

1.0

3.6

—

Ectropion of eyelid

1.67

0.61

1.6

3.0

—

Speech and linguistic disorders, excluding more controls

0.00

0.60

0.0

4.1

—

Other and unspecified degenerative diseases of nervous system

0.00

0.60

0.0

2.5

—

Benign neoplasm of other and unspecified sites

0.00

0.60

0.0

3.2

—

Amenorrhoea

0.00

0.60

0.0

3.2

—

Visual impairment including blindness (binocular or monocular)

1.57

0.60

1.9

2.8

—

Bell's palsy

1.50

0.59

3.1

3.4

—

Ulcerative ileocolitis

0.00

0.59

0.0

4.0

—

Toxic effect of contact with venomous animals

0.00

0.58

0.0

2.8

—

Cervical polyps

1.51

0.58

2.6

3.0

—

Disorders of psychological development

0.00

0.58

0.0

3.9

—

Maternal care for known or suspected abnormality of pelvic organs

0.56

0.57

2.4

3.1

—

L04AC Interleukin inhibitors

1.72

0.57

1.2

3.4

—

Malignant neoplasm of head and neck, including Hilmo

1.71

0.57

1.2

1.6

—

Other pulmonary heart/vessel disease

1.67

0.56

3.3

3.1

—

Calcific tendinitis of shoulder

1.62

0.55

3.8

3.6

—

Spontaneous rupture of synovium and tendon

1.54

0.55

1.9

3.7

—

Unspecified jaundice

1.58

0.54

4.2

3.1

—

Etanercept

1.58

0.54

1.7

3.4

—

Psychotic depression

1.58

0.54

1.5

2.5

—

Other abnormal products of conception

0.61

0.53

1.7

3.5

—

Ménière disease

1.49

0.53

3.8

2.8

—

Sequelae of infectious and parasitic diseases

1.54

0.53

4.7

3.4

—

Alzheimer’s disease (Late onset), excluding more controls

0.68

0.53

4.0

2.9

—

Disorders of tooth development and eruption

1.44

0.52

3.8

3.5

—

Overexertion and strenuous or repetitive movements

1.43

0.52

3.3

3.0

—

HSIL lesion of the cervix uteri, vagina or vulva

1.43

0.52

2.7

3.1

—

Superficial injury of head

169

0.71

0.52

1.4

3.1

—

Other disorders of bladder

100

1.40

0.51

3.6

2.8

—

Diabetic retinopathy, strict definition

127

1.33

0.51

1.7

2.6

—

Pollen allergy

1.41

0.51

3.3

3.1

—

Allergic contact dermatitis

1.47

0.50

2.4

3.2

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1.47

0.50

1.4

1.7

—

Inflammatory diseases of female pelvic organs

233

1.20

0.50

3.4

2.8

—

Problems related to lifestyle

1.39

0.50

2.1

3.2

—

Scabies, including avohilmo

1.38

0.50

1.9

3.2

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.39

0.50

3.3

—

Sequelae of infectious and parasitic diseases, including avohilmo

1.46

0.50

4.7

3.6

—

Other follicular disorders

1.46

0.50

1.0

3.6

—

Other coagulation defects

1.56

0.49

2.3

3.3

—

Arterial embolism and thrombosis

1.56

0.49

3.6

2.6

—

Bullous disorders

1.52

0.48

1.7

3.1

—

Malignant melanoma of skin

1.52

0.48

1.3

1.5

—

Hypertrophy of breast

1.45

0.48

2.5

2.8

—

Pre-eclampsia

1.45

0.48

1.6

2.9

—

Acute peritonitis

1.49

0.47

1.3

3.1

—

Adalimumab

1.46

0.46

1.1

3.0

—

Other otitis externa (chronic)

1.43

0.46

6.4

3.1

—

Spondylolisthesis/Spondylolysis

129

1.32

0.45

3.1

3.4

—

Malignant neoplasm of rectum, including Hilmo

1.37

0.44

1.3

1.7

—

Medical abortion

191

0.82

0.43

3.7

2.8

—

Thyrotoxicosis with diffuse goitre

1.41

0.43

3.0

2.9

—

Intestinal malabsorption

1.61

0.43

1.4

3.0

—

Urethral stricture

1.43

0.42

1.4

3.4

—

Early lumbar disc prolapse, operated

1.56

0.42

3.0

4.0

—

Astigmatism

1.56

0.42

2.2

3.4

—

Atrophic disorders of skin

1.35

0.41

2.5

3.0

—

Disturbances of smell and taste

1.52

0.41

1.2

3.3

—

Ulcerative proctitis

1.52

0.41

2.2

3.2

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.41

0.0

2.7

—

KRA_PSY_EATING, excluding more controls

0.00

0.41

0.0

2.6

—

Benign neoplasm: Skin of scalp and neck

0.00

0.41

0.0

3.7

—

Benign neoplasm: Skin of lower limb, including hip

0.00

0.41

0.0

2.7

—

Problems related to social environment

0.00

0.41

0.0

2.1

—

Hyperhidrosis

0.00

0.41

0.0

2.4

—

Other inflammation of vagina/vulva

0.00

0.41

0.0

2.5

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.00

0.41

0.0

2.9

—

Vascular dementia (mixed)

0.00

0.41

0.0

2.7

—

Epiphora

0.00

0.41

0.0

3.2

—

Small cell lung cancer, helper endpoint

0.00

0.41

0.0

2.6

—

Open bite

0.00

0.41

0.0

3.8

—

0.00

0.41

0.0

3.6

—

Haemangioma, any site

1.36

0.41

5.5

3.2

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

0.40

0.0

3.1

—

Short Achilles tendon (acquired)

0.00

0.40

0.0

2.7

—

Nontoxic diffuse goitre

0.00

0.40

0.0

2.6

—

Other and unspecified intracranial injuries

0.00

0.40

0.0

1.8

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.40

0.0

3.4

—

Anankastic personality disorder

0.00

0.40

0.0

4.7

—

Ectopic pregnancy

1.39

0.40

2.3

2.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.47

0.40

3.8

2.7

—

Artificial opening status

1.47

0.40

5.0

3.8

—

Dystonia

1.47

0.40

1.8

2.9

—

Excessive vomiting in pregnancy

1.47

0.40

2.0

3.2

—

Polyp of the female genital tract

1.26

0.40

2.3

2.9

—

Autonomic disorders

0.00

0.40

0.0

3.2

—

Secondary parkinsonism

0.00

0.40

0.0

3.3

—

Erosion and ectropion of cervix uteri

0.00

0.40

0.0

2.8

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.40

0.0

3.4

—

Asthma and allergy

1.45

0.40

3.2

2.6

—

Speech and linguistic disorders

0.00

0.39

0.0

4.3

—

Other bursopathies

1.34

0.39

3.5

3.2

—

Other noninflammatory disorders of vagina

1.43

0.39

2.2

2.4

—

Early lumbar disc prolapse operation

1.43

0.39

3.0

3.4

—

Peripheral retinal degeneration

0.00

0.39

0.0

4.4

—

Anisometropia and aniseikonia

0.00

0.39

0.0

3.3

—

Diffuse brain injury

0.00

0.39

0.0

3.5

—

Alzheimer disease, excluding more controls

111

0.76

0.38

4.8

2.8

—

Lichen sclerosus et atrophicus

1.36

0.38

2.6

2.7

—

Antenatal screening

0.64

0.37

3.8

3.6

—

Mixed and other personality disorders

1.35

0.37

4.0

3.3

—

Personal history of malignant neoplasm

1.35

0.37

2.8

2.9

—

Postmenopausal bleeding

1.24

0.36

2.5

2.9

—

Maternal care for known or suspected malpresentation of fetus

1.43

0.36

3.3

3.9

—

Rheumatism, unspecified

1.33

0.35

2.0

3.0

—

Tongue abnormality

1.43

0.35

3.2

3.4

—

Other/unspecified synovitis and tenosynovitis

0.63

0.35

2.0

3.0

—

Viral and other specified intestinal infections, including avohilmo

120

0.72

0.35

2.1

2.9

—

Non-invasive ventilation

116

0.74

0.35

3.5

3.9

—

Obstructed labour due to maternal pelvic abnormality

1.37

0.34

3.6

2.5

—

Other enthesopathies

209

1.20

0.33

3.9

3.3

—

Malignant neoplasm of colon, including Hilmo

1.34

0.33

3.0

1.7

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

191

0.82

0.32

1.8

3.2

—

Spontaneous abortion

153

1.18

0.31

2.1

3.1

—

Other specified/unspecified bacterial intestinal infections

1.35

0.31

1.7

3.0

—

Inflammatory diseases of the central nervous system

1.35

0.31

2.4

3.2

—

HSIL lesion of the cervix uteri

1.35

0.31

1.7

3.1

—

LSIL lesion of the cervix uteri, vagina or vulva

1.32

0.30

3.6

2.8

—

Enthesopathies of lower limb, excluding foot

142

0.77

0.30

2.5

3.6

—

Colon adenocarcinoma

1.30

0.30

2.7

1.5

—

Delivery, wide proxy

1.22

0.30

2.6

—

Lung cancer and mesothelioma

117

1.23

0.30

1.9

2.3

—

Radiculopathy

111

1.26

0.30

2.0

3.6

—

Acute nasopharyngitis (common cold)

1.24

0.29

2.1

2.8

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

185

1.19

0.29

1.7

2.8

—

Thyroiditis, ILD-related definition

1.23

0.29

1.0

3.1

—

Fracture of skull and facial bones

140

0.79

0.28

1.5

3.2

—

Salpingitis and oophoritis

1.28

0.28

3.7

2.4

—

Premature rupture of membranes

1.26

0.28

4.1

3.1

—

Faecal incontinence

1.27

0.27

2.0

2.7

—

Plantar fascial fibromatosis

1.21

0.26

2.0

3.0

—

Pre-eclampsia or eclampsia

1.28

0.26

1.6

2.8

—

Other peripheral vertigo

0.70

0.26

1.2

2.8

—

Cervicocranial syndrome

0.70

0.26

3.2

3.1

—

Diabetic maculopathy

1.26

0.25

2.6

2.8

—

Fibroblastic disorders

188

1.17

0.25

1.8

3.1

—

Allergic asthma (mode), excluding more controls

1.22

0.25

2.4

3.1

—

Other disorders of cornea

1.20

0.25

4.9

2.7

—

Allergic asthma (mode)

1.19

0.24

2.4

3.0

—

Cervicobrachial syndrome

137

0.80

0.24

2.1

3.7

—

L02BG Aromatase inhibitors

209

0.85

0.23

2.3

2.8

—

Lesion of plantar nerve

1.32

0.23

1.2

3.0

—

Perineal laceration during delivery

1.30

0.23

3.0

—

Malignant neoplasm of rectum

1.32

0.23

1.2

1.6

—

Carcinoma in situ of other and unspecified digestive organs

1.28

0.23

1.6

3.4

—

Demyelinating diseases of the central nervous system

1.28

0.23

11.4

3.2

—

Infections of genitourinary tract in pregnancy

1.28

0.23

2.2

3.0

—

Other problems related to primary support group, including family circumstances

1.28

0.23

2.0

3.5

—

Pedestrian injured in transport accident

1.25

0.22

1.4

3.5

—

Viral infections of the central nervous system

1.25

0.22

2.6

3.1

—

Lateral epicondylitis

1.27

0.22

4.6

3.8

—

Other/unspecified reactive arthropathies

1.22

0.22

1.8

3.2

—

Benign neoplasm of ovary

107

1.22

0.21

2.3

2.6

—

Tuberculosis

1.19

0.21

4.6

2.7

—

Thyroiditis

1.19

0.21

1.2

3.1

—

Preterm labour and delivery

107

1.21

0.21

3.7

2.7

—

Carcinoma in situ of breast, other/unspecified

0.00

0.21

0.0

2.0

—

Operations for atrial fibrillation

0.00

0.21

0.0

3.7

—

Beningn neoplasm: Meninges, unspecified

0.00

0.21

0.0

1.9

—

Benign neoplasm: Short bones of upper limb

0.00

0.21

0.0

3.5

—

Late syphilis, including avohilmo

0.00

0.21

0.0

3.3

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

0.21

0.0

5.1

—

Torticollis

0.00

0.21

0.0

2.4

—

Other specified/unspecified deforming dorsopathies

0.00

0.21

0.0

4.9

—

Injury of muscle and tendon at forearm level

0.00

0.21

0.0

3.0

—

Sexual dysfunction

0.00

0.21

0.0

5.6

—

Communicating hydrocephalus

0.00

0.21

0.0

3.2

—

Toxic effect of alcohol

0.00

0.21

0.0

3.4

—

Burn and corrosion of head and neck

0.00

0.21

0.0

3.5

—

Pneumoconiosis due to asbestos and other mineral fibres

0.00

0.21

0.0

2.5

—

Papilloedema, unspecified

0.00

0.21

0.0

3.5

—

Major anomalies of jaw size

0.00

0.21

0.0

4.9

—

Other congenital malformations of face and neck

0.00

0.21

0.0

3.9

—

Abnormal findings on diagnostic imaging of breast

0.00

0.21

0.0

3.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

0.21

0.0

5.1

—

Juvenile rheumatoid arthirtis

0.00

0.21

0.0

2.1

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

0.21

0.0

3.7

—

Contusion of toe(s) without damage to nail

0.00

0.21

0.0

3.1

—

Allergic purpura

0.00

0.21

0.0

3.3

—

Complications of the puerperium, not elsewhere classified

0.00

0.21

0.0

2.9

—

Female infertility, associated with anovulation

0.00

0.21

0.0

3.7

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

4.3

—

Specific development disorders of speech and language

0.00

0.21

0.0

3.9

—

Other noninflammatory disorders of vulva and perineum

1.16

0.21

4.0

2.7

—

Traumatic subdural haemorrhage

0.76

0.21

4.4

2.9

—

Endometriosis ASRM stages 3,4

105

0.76

0.21

2.8

2.7

—

Fistulae involving female genital tract

0.00

0.21

0.0

2.9

—

Other degenerative diseases of the basal ganglia

0.00

0.21

0.0

4.2

—

Procedures for purposes other than remedying health state

0.00

0.21

0.0

2.8

—

Syphilis, including avohilmo

0.00

0.21

0.0

4.3

—

Syphilis

0.00

0.21

0.0

4.3

—

Abscess of Bartholin gland

0.00

0.21

0.0

2.8

—

Algoneurodystrophy

0.00

0.21

0.0

2.7

—

Obsessive-compulsive disorder

0.00

0.21

0.0

4.0

—

Female genital prolapse

0.84

0.20

3.4

2.9

—

Adhesive capsulitis of shoulder

123

0.81

0.20

3.8

3.1

—

Circumscribed brain atrophy

0.00

0.20

0.0

4.0

—

Other and unspecified nail disorders

0.00

0.20

0.0

2.8

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.20

0.0

2.9

—

Exposure to smoke, fire and flames

0.00

0.20

0.0

3.1

—

Erythema intertrigo

0.00

0.20

0.0

4.0

—

0.00

0.20

0.0

4.1

—

LSIL lesion of the vulva

0.00

0.20

0.0

3.5

—

Symptoms and signs involving emotional state

0.00

0.20

0.0

2.6

—

Maternal care for known or suspected disproportion

0.00

0.20

0.0

3.1

—

Eating disorder

0.00

0.20

0.0

3.0

—

Other aneurysm

1.25

0.20

2.2

2.6

—

Respiratory insufficiency

1.22

0.20

2.3

2.6

—

Early onset COPD, excluding more controls

115

0.78

0.20

1.6

2.6

—

Left bundle-branch block

1.20

0.19

3.3

2.8

—

Hypertrophy of breast in women and men

1.21

0.19

2.4

2.9

—

Abscess of anal and rectal regions

1.15

0.19

1.2

3.4

—

Migraine without aura and triptan purchases

1.15

0.19

2.0

3.4

—

Colorectal adenocarcinoma

1.22

0.19

2.2

1.6

—

Other and unspecified injuries of head

1.13

0.18

1.2

2.9

—

Vascular disorders of the intestines

1.13

0.18

2.3

3.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

128

1.17

0.18

1.6

3.4

—

Irregular menses

163

0.87

0.18

3.3

2.8

—

Sequelae of injuries of lower limb

1.21

0.18

1.9

3.0

—

Trigger finger

100

1.20

0.18

1.3

3.2

—

Ankylosing spondylitis

1.19

0.18

1.1

3.7

—

Female infertility

0.82

0.18

1.7

3.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.11

0.17

3.3

3.0

—

Special screening examination for other diseases and disorders

0.75

0.17

1.2

3.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.71

0.17

1.6

2.9

—

Deforming dorsopathies

186

1.13

0.16

2.9

3.4

—

Nonalcoholic fatty liver disease

1.18

0.16

3.1

3.2

—

Adenomyosis (Endometriosis of uterus)

1.17

0.16

1.6

2.7

—

Shoulder lesions

354

1.07

0.16

3.3

3.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.11

0.16

3.4

2.9

—

Delivery

108

1.12

0.15

3.0

2.8

—

Viral and other specified intestinal infections

1.14

0.15

2.1

2.7

—

Medicines for HER+ breast cancer

228

0.90

0.15

2.4

2.9

—

Cervical disc disorders

284

1.09

0.15

2.0

3.3

—

Non-allergic asthma (mode), excluding more controls

1.09

0.14

2.8

2.2

—

Examination and observation for other reasons

220

0.92

0.14

1.9

3.2

—

Sarcoidosis

0.79

0.14

3.6

3.1

—

Unspecified lump in breast

0.79

0.14

2.1

2.7

—

Trochanteric bursitis

112

1.16

0.14

3.5

2.8

—

Noninflammatory disorders of female genital tract

1.12

0.14

2.3

2.9

—

Irritable bowel syndrome

151

1.13

0.13

2.3

3.3

—

Female infertility, cervical, vaginal, other or unspecified origin

0.81

0.13

1.8

3.2

—

Rotator cuff syndrome

350

0.94

0.12

3.7

3.2

—

Pregnancy, childbirth and the puerperium

1.13

0.11

2.5

2.4

—

Peripheral artery disease

327

1.06

0.11

2.1

2.8

—

Ganglion

124

1.13

0.11

3.0

3.5

—

Anomalies of dental arch relationship, including avohilmo

1.14

0.10

1.6

3.2

—

Palmar fascial fibromatosis [Dupuytren]

135

1.11

0.09

1.7

3.0

—

Viral infections of the central nervous system, including avohilmo

1.09

0.09

2.6

3.1

—

Injury of eye and orbit

1.15

0.09

2.1

3.6

—

Pregnancy with abortive outcome

192

1.06

0.09

3.0

2.8

—

Injury of unspecified body region

1.11

0.09

1.5

2.9

—

Melanocytic naevi, other sites/unspecified

1.09

0.08

3.8

3.0

—

Panic disorder

1.03

0.08

2.2

3.3

—

Nail disorders

0.83

0.08

1.2

3.1

—

Other congenital malformations, including avohilmo

0.79

0.08

2.6

3.3

—

Other enthesopathy of foot (+metatarsalgia)

0.77

0.08

2.2

3.1

—

Obstructed labour due to malposition and malpresentation of fetus

1.10

0.08

7.3

3.2

—

Other/unspecified enthesopathies, not elsewhere classified

1.09

0.08

4.1

3.1

—

Generalized anxiety disorder

1.09

0.08

1.6

3.2

—

Hydronephrosis

1.06

0.08

2.4

4.0

—

Neuromuscular dysfunction of bladder

1.03

0.07

6.6

3.4

—

Disorders of muscles

0.86

0.07

2.2

3.5

—

Benign neoplasm of breast

0.84

0.07

1.7

2.5

—

Postpartum hemorraghe, all women as controls

1.08

0.07

3.8

3.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.07

0.07

2.5

3.2

—

Single spontaneous delivery

108

1.08

0.07

3.0

2.7

—

Postpartum haemorrhage

1.05

0.07

3.8

3.1

—

Endometriosis of ovary

1.02

0.07

2.8

2.9

—

Other degenerative diseases of the nervous system

164

0.93

0.07

5.9

3.0

—

Gestational [pregnancy-induced] hypertension

1.07

0.07

2.1

3.0

—

False labour

0.84

0.07

4.5

3.8

—

Valvular operations

1.02

0.07

1.8

3.0

—

L02BA Anti-estrogens

0.85

0.06

3.0

2.6

—

Other noninflammatory disorders of uterus, except cervix

1.09

0.06

3.4

2.9

—

Disorders of breast

244

1.05

0.05

2.6

2.9

—

Disorder of lipoprotein metabolism, unspecified

1.10

0.04

1.9

3.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

106

0.94

0.04

4.3

3.0

—

Endometriosis

0.94

0.03

2.0

2.9

—

Uterine polyps

1.06

0.03

2.1

2.9

—

Convulsions, not elsewhere classified

126

0.94

0.02

1.3

2.9

—

Other maternal disorders predominantly related to pregnancy

180

0.97

0.01

2.3

3.0

—

Pregnancy hypertension

157

0.97

0.00

1.9

3.0

—

Cervicalgia

137

1.02

0.00

1.7

3.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

307

1.00

0.00

2.2

2.7

—

Lesion of ulnar nerve

1.05

0.00

1.4

3.8

—

Peripheral artery operations in Hilmo

108

1.02

0.00

1.8

3.1

—

Impingement syndrome of shoulder

188

1.01

0.00

2.8

3.4

—

Pre-eclampsia or poor fetal growth

108

1.01

0.00

1.6

3.2

—

Superficial injury of hip and thigh

116

1.03

0.00

3.9

3.2

—

Other contact dermatitis

0.98

0.00

1.2

3.5

—

Other disorders of breast

0.99

0.00

3.4

2.5

—

Overjet

0.00

0.0

3.4

—

Malnutrition

0.00

0.0

2.1

—

Cellulitis of external ear

0.00

0.0

2.3

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

0.0

2.4

—

Respiratory tuberculosis, confirmed, including avohilmo

0.00

0.0

3.7

—

Specific development disorders of scholastic skills

0.00

0.0

2.3

—

Cauda equina syndrome

0.00

0.0

2.5

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

2.8

—

Primary adrenocortical insufficiency

0.00

0.0

2.5

—

Other eating disorders

0.00

0.0

3.3

—

Arthropathy in ulcerative colitis

0.00

0.0

3.0

—

Disorder of thyroid, unspecified

0.00

0.0

2.1

—

Benign neoplasm: Cerebral meninges

0.99

0.00

3.1

2.8

—

Exposure to other and unspecified man-made environmental factors

0.00

0.0

2.7

—

Carcinoma in situ of breast, intraductal

0.98

0.00

3.0

2.7

—

Malignant neoplasm of rectosigmoid junction

0.00

0.0

1.2

—

Other congenital malformations of intestine, including avohilmo

0.00

0.0

3.0

—

Benign neoplasm: Appendix

0.00

0.0

2.5

—

Drug-induced systemic lupus erythematosus

0.00

0.0

2.8

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

0.00

0.0

3.0

—

Causalgia

0.00

0.0

3.7

—

Bruxism

0.00

0.0

4.1

—

Senility

0.00

0.0

2.4

—

Otosclerosis

0.97

0.00

5.2

3.1

—

Nonalcoholic steatohepatitis

0.00

0.0

2.8

—

Benign neoplasm: Uterine tubes and ligaments

0.00

-0.00

0.0

2.8

—

Brain glioblastoma and astrocytoma

0.00

-0.00

0.0

1.0

—

Endometriosis of pelvic peritoneum

0.94

-0.00

2.0

3.3

—

Follow-up examination after treatment for malignant neoplasms

1.00

-0.00

1.7

2.8

—

Routine general health check-up of defined subpopulation

0.00

-0.00

0.0

1.6

—

Postpartum hemorraghe, parous women as controls

0.90

-0.00

3.8

3.4

—

Failed induction of labour

0.00

-0.00

0.0

3.4

—

Other disorders of thyroid

0.00

-0.00

0.0

2.3

—

Dislocation of lens

0.00

-0.00

0.0

2.2

—

Lagophthalmos

0.00

-0.00

0.0

2.4

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

-0.00

0.0

3.6

—

Varus deformity, not elsewhere classified

0.00

-0.00

0.0

2.1

—

Serous carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.8

—

Migraine with aura, drug-induced

0.00

-0.00

0.0

2.4

—

Cicatricial alopecia [scarring hair loss]

0.00

-0.00

0.0

2.6

—

Laparoscopic left hemicolectomy

0.00

-0.00

0.0

2.1

—

Other nonscarring hair loss

0.00

-0.00

0.0

3.3

—

Hypertrophy of (infrapatellar) fat pad

0.00

-0.00

0.0

3.6

—

Other obstetric conditions, not elsewhere classified

0.90

-0.00

4.5

3.4

—

Alcohol abuse counselling and surveillance

0.00

-0.00

0.0

5.9

—

Sequelae of other accidents

0.00

-0.00

0.0

1.6

—

Other abnormal auditory perceptions

0.00

-0.00

0.0

3.3

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

2.0

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

-0.00

0.0

4.1

—

Congenital malformations of breast, including avohilmo

0.00

-0.00

0.0

3.4

—

Other corneal oedema

0.00

-0.00

0.0

2.6

—

Diastasis of muscle

0.00

-0.00

0.0

3.0

—

Other disorders of choroid

0.00

-0.00

0.0

2.3

—

Other protozoal intestinal diseases, including avohilmo

0.00

-0.00

0.0

6.6

—

Thyroiditis, unspecified

0.00

-0.00

0.0

4.6

—

Benign neoplasm: Oesophagus

0.00

-0.00

0.0

2.8

—

Pedestrian injured in other and unspecified transport accidents

0.00

-0.00

0.0

2.5

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

2.3

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

-0.00

0.0

5.0

—

Benign neoplasm: Spinal cord

0.00

-0.00

0.0

2.4

—

Dyshidrosis [pompholyx]

0.00

-0.00

0.0

2.8

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

2.8

—

Late syphilis

0.00

-0.00

0.0

2.0

—

Anxious personality disorder

0.00

-0.00

0.0

4.1

—

Exposure to excessive natural cold

0.00

-0.00

0.0

4.2

—

Dependent personality disorder

0.00

-0.00

0.0

3.5

—

Medical treatment for female infertility

0.92

-0.00

1.8

3.4

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

2.2

—

Carcinoma in situ of vulva

0.00

-0.00

0.0

3.3

—

Malignant neoplasm of testis, including Hilmo

0.00

-0.00

0.0

1.2

—

HSIL lesion of the vagina

0.00

-0.00

0.0

4.6

—

Acute drug-induced interstitial lung disorder

0.00

-0.00

0.0

2.6

—

Bitten or struck by other mammals

1.00

-0.00

1.7

3.1

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.5

—

Migraine without aura, drug-induced

0.00

-0.00

0.0

2.8

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

0.00

-0.00

0.0

2.8

—

Human immunodeficiency virus [HIV] disease, including avohilmo

0.00

-0.00

0.0

1.4

—

Shoulder region

0.00

-0.00

0.0

2.1

—

Chronic hepatitis NAS

0.00

-0.00

0.0

2.5

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.00

-0.00

0.0

3.8

—

Other acute disseminated demyelination

0.00

-0.00

0.0

4.8

—

Arteriovenous malformation of cerebral vessels

0.00

-0.00

0.0

3.6

—

Congenital malformations of breast

0.00

-0.00

0.0

3.4

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

3.7

—

Use of rotigotine

0.00

-0.00

0.0

2.1

—

Disorders of brain, other and unspecified

0.00

-0.00

0.0

2.4

—

Premature separation of placenta [abruptio placentae]

0.00

-0.00

0.0

3.3

—

Type 1 diabetes, wide definition, subgroup 2

0.00

-0.00

0.0

2.4

—

Poisoning by medicine, drug-induced

0.00

-0.00

0.0

3.0

—

Endometriosis ASRM stages 1,2

0.88

-0.00

2.0

2.7

—

Other bursitis of knee

0.00

-0.00

0.0

6.7

—

Migraine with aura and triptan purchases

0.89

-0.00

2.0

3.6

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

-0.00

0.0

2.2

—

Disorders of speech understanding and production

0.00

-0.00

0.0

2.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

2.6

—

Open wound of shoulder and upper arm

0.00

-0.00

0.0

3.8

—

Obstructive hydrocephalus

0.00

-0.00

0.0

2.5

—

Horner syndrome

0.00

-0.00

0.0

2.5

—

Vitiligo

0.00

-0.00

0.0

3.0

—

Benign neoplasm: Bladder

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of larynx

0.00

-0.00

0.0

1.2

—

Osteitis due to dental implant

0.00

-0.00

0.0

2.6

—

Supervision of normal pregnancy

0.93

-0.00

2.9

3.7

—

Respiratory tuberculosis, confirmed

0.00

-0.00

0.0

3.8

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

0.00

-0.00

0.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.00

-0.00

0.0

1.4

—

Von Willebrand disease

0.00

-0.00

0.0

3.3

—

Malignant neoplasm of testis

0.00

-0.00

0.0

1.2

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

-0.00

0.0

1.4

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

-0.00

0.0

2.8

—

Small cell lung cancer

0.00

-0.00

0.0

1.1

—

Traumatic ischaemia of muscle

0.00

-0.00

0.0

5.8

—

Optic atrophy, wide definition

0.00

-0.00

0.0

2.4

—

Maternal care for other conditions predominantly related to pregnancy

0.93

-0.00

2.8

4.1

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

-0.00

0.0

2.3

—

Optic atrophy

0.00

-0.00

0.0

2.4

—

Venous complications and haemorrhoids in pregnancy

0.00

-0.00

0.0

3.9

—

Other specified and unspecified disorders of eyelid

0.00

-0.00

0.0

2.8

—

Disorders of optic nerve and visual pathways

0.86

-0.00

2.0

2.9

—

Polyhydramnios

0.00

-0.00

0.0

3.9

—

Tarsal tunnel syndrome

0.00

-0.00

0.0

3.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

-0.00

0.0

1.1

—

Fasciculation

0.00

-0.00

0.0

3.0

—

Unspecified maternal hypertension

0.00

-0.00

0.0

2.8

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

2.4

—

Inflammation of lacrimal passages (chronic)

0.00

-0.00

0.0

2.7

—

Hypotension due to drugs

0.00

-0.00

0.0

2.3

—

Hepatocellular carcinoma

0.00

-0.00

0.0

1.2

—

Non-allergic asthma (mode)

0.95

-0.00

2.8

2.3

—

Foreign body in genitourinary tract

0.00

-0.00

0.0

1.6

—

Brain glioblastoma, helper endpoint

0.00

-0.00

0.0

2.1

—

Hypothermia

0.00

-0.00

0.0

1.2

—

Other specified and unspecified strabismus

0.00

-0.00

0.0

2.3

—

Stenosis and insufficiency of lacrimal passages

0.95

-0.00

3.0

2.9

—

Malignant neoplasm of larynx, including Hilmo

0.00

-0.00

0.0

1.2

—

Cerebral atherosclerosis

0.00

-0.00

0.0

2.3

—

Adhesive middle ear disease

0.00

-0.00

0.0

2.3

—

Vestibular neuronitis

0.87

-0.00

6.5

3.0

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

-0.00

0.0

1.2

—

Small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.1

—

Other abortion

0.00

-0.00

0.0

3.4

—

Premenstrual syndrome

0.00

-0.00

0.0

4.8

—

Spinal osteochondrosis

0.00

-0.00

0.0

4.3

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

-0.00

0.0

3.4

—

Foreign body in ear

0.00

-0.00

0.0

3.0

—

Tibial collateral bursitis [Pellegrini-Stieda]

0.00

-0.00

0.0

3.6

—

Use of glatiramer acetate

0.00

-0.00

0.0

3.8

—

Iliotibial band syndrome

0.00

-0.00

0.0

3.5

—

Venous complications and haemorrhoids in the puerperium

0.00

-0.00

0.0

1.6

—

Other specified/unspecified necrotizing vasculopathies

0.00

-0.00

0.0

2.3

—

Atlantoaxial subluxation

0.00

-0.00

0.0

2.8

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

-0.00

0.0

3.7

—

Metatarsalgia

0.85

-0.00

2.2

3.2

—

Adult respiratory distress syndrome

0.00

-0.00

0.0

3.3

—

Ehlers-Danlos syndrome, including avohilmo

0.00

-0.00

0.0

4.0

—

Impacted maxillary molar

0.00

-0.00

0.0

2.7

—

Other protozoal intestinal diseases

0.00

-0.00

0.0

3.8

—

Other bursitis, not elsewhere classified

0.00

-0.00

0.0

2.5

—

Other benign neoplasm of uterus: Cervix uteri

0.00

-0.00

0.0

3.8

—

Synovial cyst of popliteal space [Baker]

0.85

-0.00

2.0

3.0

—

Other bursitis of elbow

0.00

-0.00

0.0

8.4

—

Toxic effect of carbon monoxide

0.00

-0.00

0.0

2.0

—

Respiratory conditions due to other external agents

0.00

-0.00

0.0

2.1

—

Other forms of systemic lupus erythematosus

0.00

-0.00

0.0

2.8

—

Human immunodeficiency virus [HIV] disease

0.00

-0.00

0.0

1.4

—

Ovarian hyperstimulation (induction)

0.00

-0.00

0.0

2.5

—

Androgenic alopecia

0.00

-0.00

0.0

2.8

—

Pemphigus

0.00

-0.00

0.0

2.8

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

-0.00

0.0

2.1

—

Complications following infusion, transfusion and therapeutic injection

0.00

-0.00

0.0

3.8

—

Localized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

3.4

—

Hereditary ataxia

0.00

-0.00

0.0

2.3

—

Other lack of coordination

0.00

-0.00

0.0

3.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

-0.00

0.0

2.8

—

Benign mammary dysplasia

0.95

-0.00

1.9

2.6

—

Endometriosis of fallopian tube

0.00

-0.00

0.0

3.9

—

0.90

-0.00

5.9

3.0

—

Other benign neoplasm of uterus: Corpus uteri

0.00

-0.00

0.0

2.3

—

Benign neoplasm: Other/unspecified site

0.00

-0.00

0.0

2.3

—

0.00

-0.00

0.0

4.2

—

Patellar tendinitis

0.00

-0.00

0.0

5.0

—

Endometriosis of intestine

0.00

-0.00

0.0

4.8

—

Palindromic rheumatism

0.00

-0.00

0.0

2.1

—

Mixed connective tissue disease

0.00

-0.00

0.0

3.8

—

Congenital malformations of uterus and cervix

0.00

-0.00

0.0

4.5

—

Other superficial mycoses

0.00

-0.00

0.0

4.2

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lambda light chains [Mass/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS